TOVX Latest Press Releases

-- May 5, 2026 --

Theriva Biologics Reports First Quarter 2026 Operational Highlights and Financial Results Globe Newswire 4:30 PM

-- April 17, 2026 --

Theriva Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting Globe Newswire 4:05 PM

-- March 23, 2026 --

Theriva Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma Globe Newswire 8:00 AM

-- March 12, 2026 --

Theriva Biologics Reports Full-Year 2025 Operational Highlights and Financial Results Globe Newswire 8:00 AM

-- February 19, 2026 --

$30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum Globe Newswire 11:00 AM

-- February 18, 2026 --

Theriva Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications Globe Newswire 8:00 AM

-- February 3, 2026 --

Theriva Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026 Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software